Nuwellis (NUWE) Gross Profit (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.81% |
| Dec 31, 2025 | 14.46% |
| Sep 30, 2025 | 50.84% |
| Jun 30, 2025 | -10.22% |
| Mar 31, 2025 | -21.25% |
| Dec 31, 2024 | -18.18% |
| Sep 30, 2024 | 12.35% |
| Jun 30, 2024 | 23.76% |
| Mar 31, 2024 | -14.19% |
| Dec 31, 2023 | 0.51% |
| Sep 30, 2023 | 20.40% |
| Jun 30, 2023 | 7.50% |
| Mar 31, 2023 | -19.83% |
| Dec 31, 2022 | 5.72% |
| Sep 30, 2022 | 18.44% |
| Jun 30, 2022 | -3.54% |
| Mar 31, 2022 | 23.27% |
| Dec 31, 2021 | -20.18% |
| Sep 30, 2021 | -25.88% |
| Jun 30, 2021 | 56.42% |
| Mar 31, 2021 | -15.71% |
| Dec 31, 2020 | 30.52% |
| Sep 30, 2020 | -26.77% |
| Jun 30, 2020 | 43.76% |
| Mar 31, 2020 | 20.17% |
| Dec 31, 2019 | -2.53% |
| Sep 30, 2019 | -15.44% |
| Jun 30, 2019 | 39.64% |
| Mar 31, 2019 | 17.09% |
| Dec 31, 2018 | 14.96% |
| Sep 30, 2018 | 95.63% |
| Jun 30, 2018 | 68.38% |
| Mar 31, 2018 | 780.00% |
| Dec 31, 2017 | -111.43% |
| Sep 30, 2017 | -29.44% |
| Jun 30, 2017 | -35.92% |
| Mar 31, 2017 | 75.91% |
| Dec 31, 2016 | -38.20% |